The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction
Abstract
Aim. To study effects of various streptokinase thrombolytic therapy (TLT) and following antithrombotic therapy variants on coagulation hemostasis and fibrinolysis parameters; to prove the opportunity to use reduced streptokinase doses in acute myocardial infarction (AMI) treatment. Material and methods. In total, 56 AMI patients received standard streptokinase dose, 1 500 000 U; 61 patients received reduced streptokinase dose, 750 000 U. In each group, thrombolysis was followed by various antithrombotic regimens. In all participants, coagulation hemostasis and fibrinolysis parameters were measured before TLT, 3 hours, 5, 10, and 20 days later. Results. Reduced streptokinase dose influenced coagulation hemostasis and fibrinolysis parameters similar to standard dose. No benefits for any special post-thrombolysis antithrombotic therapy regimen were registered in AMI patients. Conclusion. In AMI patients, reduced streptokinase doses could be used for TLT. After TLT, aspirin monotherapy can be recommended.
About the Authors
Ya. L. Gabinsky
Clinical Center «Cardiology». Yekaterinburg
Russian Federation
Russian Federation
S. G. Kalinina
Clinical Center «Cardiology». Yekaterinburg
Russian Federation
Russian Federation
References
1. Rentrop KP. Restoration of antegrade flow in acute myocardial infarction: the first 15years. JACC 1995; 25(Supp7): 15-25.
2. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial) Infarction. JACC 1996; 28: 1328-428.
3. Руда М.Я. Что нужно знать практическому врачу о тромболитической терапии при инфаркте миокарда. Сердце 2002; 1(1): 9-12.
4. Mueller RL, Scheidt S. History of drugs for thrombotic disease. Discovery, development and directions for the future. Circulation 1994; 89: 432-49.
5. Панченко Е.П., Добровольский А.Б. Тромбозы в кардиологии. Механизмы развития и возможности терапии. Москва «Спорт и культура» 1999; 464 с.
6. Boersma E, Mercado N, Poldermans D, et al. Acute myocardial infarction. Lancet 2003; 361: 847-58.
7. World Health Organization. The WHO Model List of Essential Medicines.14th edition (March 2005)http://whqlibdoc.who.int/ hq/2005/a87017_eng.pdf.
8. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarcto Miocardo (GISSI). Effectiveness of Intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1: 397- 401.
9. ISSIS-2 (second international study of infarct survival) collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 1787cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.
10. The ISAM study group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): mortality, morbidity and infarct size at 21 days. N Engl J Med 1986; 314: 1465-71.
11. Fibrinolytic therapy trialists’ ( FTT) collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more then 1000 patients. Lancet 1994; 343: 311-22.
12. Сидоренко Б.А., Преображенский Д.В. Антитромботические препараты, применяемые для лечения сердечно- сосудистых заболеваний. Часть III. Кардиология 1996; 3: 82-94.
13. Крыжановский В.А. Тромболизис при инфаркте миокарда. Кардиология 2001; 6: 67-79.
14. Parmley WW. Cost-effectiveness of reperfusion strategies. Am Heart J 1999; 138: S142-52.
15. Hermentin P, Cuesta-Linker T, Weisse J, et al. Соmparative analysis of the activity and content of different streptokinase preparations. Eur Heart J 2005; 26: 933-40.
16. Аверков О.В., Явелов И.С. Новое в антитромботическом лечении острых коронарных синдромов (по материалам XIX конгресса Европейского кардиологического общества. Стокгольм, 24-28 августа 1997г.). Кардиология 1998; 4: 62-73.
17. Лечение острого инфаркта миокарда с подъемом сегментаST (рабочая группа Европейского общества кардиологов по острому инфаркту миокарда с подъемом сегмента ST, F.Van de Wеrf (председатель)). РФК 2005; 2: 62-95.
18. Гнездилова Н.Ю. Сопоставление эффективности и последствий различных методов тромболитической терапии у больных инфарктом миокарда. Н.Ю. Гнездилова, Т.В. Хлевчук, И.Н. Бокарев. VII Национальная конференция. Новое в изучении патогенеза, диагностике, профилактике и лечении патологии гемостаза. Под ред. проф. И.Н. Бокарева и проф. В.А. Макарова. Москва 2002; 43-4.
19. Марков В.А. ЭКГ-критерии реперфузии миокарда при внутривенном быстром введении нативной стрептокиназы у больных инфарктом миокарда. В.А. Марков, И.В. Максимов, В.И. Варваренко. Актуальные вопросы кардиологии. Томск «Издательство ТГУ» 1994; Вып. 8: 85-9.
20. Roux S, Christeller S, Ludin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a metaanalysis. JACC 1992; 19: 671-7.
21. ISSIS-2 (second international study of infarct survival) collaborative group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 1787cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.
22. White HD, Yusuf S. Issues regarding the use of heparin following streptokinase therapy. Thrombosis Thrombolysis 1995; 2: 5-10.
23. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee to Revise the 1999 Guidelines on the Management of patient with Acute Myocardial Infarction). Circulation 2004; 110: 588-636.
24. The GUSTO investigators. An international randomized trial comparing four thrombolytic –strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
Review
For citations:
Gabinsky Ya.L., Kalinina S.G. The effects of various streptokinase thrombolysis regimens on coagulation hemostasis and fibrinolysis in acute myocardial infarction. Cardiovascular Therapy and Prevention. 2006;5(6):61-69. (In Russ.)
Views:
753
Email this article 
